FT839 in Autoimmune Diseases
for ANCA-Associated Vasculitis (AAV)
1 location in Fullerton
Sponsor: Fate Therapeutics
Sex: All·Age: 18 - 70
Code: NCT07800871·Phase 1, Phase 2·Recruiting·Listed Sep 2, 2026
Paid Clinical Trials in Fullerton, CA
As of September 2026, 90 paid clinical trials are recruiting in Fullerton, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fullerton offers studies at sites including Providence Medical Foundation for conditions such as Carcinoma, Non-Small-Cell Lung, Advanced Solid Tumor, Breast Neoplasms, Esophageal Squamous Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fullerton
Trials by drug in Fullerton
Filter results
Filter results
Newly added in Fullerton
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
84 clinical trials
Get a weekly email when new trials open in Fullerton, CA.
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
for Neovascular Age-related Macular Degeneration
Drug: Aflibercept
Sites in Fullerton, Long Beach +52 more locations
Sponsor: Amgen
Sex: All·Age: 50+
Code: NCT07614776·Phase 3·Recruiting·Listed May 2026
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for Solid Tumors
Drug: INCB161734
Sites in Fullerton, Orange +67 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07522073·Phase 3·Recruiting·Listed Apr 2026
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for Lupus Erythematosus, Systemic
Drug: Nipocalimab
Sites in Fullerton, La Palma +34 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18 - 75
Code: NCT07438496·Phase 3·Recruiting·Listed Feb 2026
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for Pancreatic Cancer
Sites in Fullerton, Orange +47 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT07409272·Phase 3·Recruiting·Listed Feb 2026
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
for Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Ixo-vec
Sites in Fullerton, Huntington Beach +77 more locations
Sponsor: Adverum Biotechnologies, Inc.
Sex: All·Age: 50+
Code: NCT07482176·Phase 3·Recruiting·Listed Mar 2026
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
Drug: Bevacizumab
Sites in Fullerton, Los Alamitos +73 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for Squamous Cell Carcinoma of Head and Neck
Drug: Amivantamab
Sites in Fullerton, Los Angeles +45 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07276399·Phase 3·Recruiting·Listed Dec 2025
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for Non-small Cell Carcinoma
Sites in Fullerton, Vista +221 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for Advanced/Metastatic Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Fullerton, Los Angeles +42 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227298·Phase 1, Phase 2·Recruiting·Listed Nov 2025
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Fullerton, Orange +43 more locations
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for End Stage Kidney Disease
Drug: Clazakizumab
Sites in Fullerton, La Palma +147 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
Drug: INCB123667
Sites in Fullerton, Orange +55 more locations
Sponsor: Incyte Corporation
Sex: Female·Age: 18+
Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Fullerton, Orange +123 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for Melanoma
Sites in Fullerton, Orange +89 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
Drug: Ribociclib
Sites in Fullerton, Orange +72 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for Radiographic Axial Spondyloarthritis
Drug: Tulisokibart
Sites in Fullerton, Huntington Beach +32 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18 - 80
Code: NCT07133633·Phase 2·Recruiting·Listed Aug 2025
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for Breast Neoplasms
Sites in Fullerton, Whittier +61 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06966700·Phase 3·Recruiting·Listed May 2025
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
for Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Sites in Fullerton, Torrance +31 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06806033·Phase 2·Recruiting·Listed Feb 2025
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for Breast Neoplasms
Sites in Fullerton +39 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06312176·Phase 3·Recruiting·Listed Mar 2024
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for Parkinson's Disease
Drug: Prasinezumab
Sites in Fullerton, Pasadena +51 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 85
Code: NCT07174310·Phase 3·Recruiting·Listed Sep 2025
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for Carcinoma, Non-Small-Cell Lung
Drug: Adagrasib
Sites in Fullerton, Long Beach +47 more locations
Sponsor: Mirati Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT06875310·Phase 3·Recruiting·Listed Mar 2025
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: Pegcetacoplan
Sites in Fullerton, Santa Ana +76 more locations
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All·Age: 60+
Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Fullerton, Buena Park +2386 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for Carcinoma, Non-Small-Cell Lung
Drug: Intismeran autogene
Sites in Fullerton, Long Beach +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for Diffuse Large B-Cell Lymphoma
Drug: Rituximab
Sites in Fullerton, Los Alamitos +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06717347·Phase 3·Recruiting·Listed Dec 2024
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for Geographic Atrophy
Sites in Fullerton, Pasadena +43 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 60+
Code: NCT06635148·Phase 2, Phase 3·Recruiting·Listed Oct 2024
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for Breast Cancer
Sites in Fullerton, Whittier +47 more locations
Sponsor: Greenwich LifeSciences, Inc.
Sex: All·Age: 18 - 100
Code: NCT05232916·Phase 3·Recruiting·Listed Feb 2022
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
for Psoriatic Arthritis
Drug: Bimekizumab
Sites in Fullerton, Whittier +28 more locations
Sponsor: UCB Biopharma SRL
Sex: All·Age: 18+
Code: NCT07290036·Phase 1·Recruiting·Listed Dec 2025
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
for Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Drug: Avacopan
Sites in Fullerton, Torrance +56 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT06072482·Phase 4·Recruiting·Listed Oct 2023
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
for Non-Small Cell Lung Cancer
Drug: sigvotatug vedotin
Sites in Fullerton +74 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06758401·Phase 3·Recruiting·Listed Jan 2025
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostate Cancer
Sites in Fullerton, Duarte +19 more locations
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT04221542·Phase 1·Recruiting·Listed Jan 2020
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for Carcinoma, Non-Small Cell Lung
Drug: sigvotatug vedotin
Sites in Fullerton, Los Alamitos +102 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04389632·Phase 1·Recruiting·Listed May 2020
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for Non Small Cell Lung Carcinoma
Sites in Fullerton, Santa Monica +21 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06772623·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
for Liver Neoplasms
Sites in Fullerton, Newport Beach +28 more locations
Sponsor: HistoSonics, Inc.
Sex: All·Age: 22+
Code: NCT06486454·Recruiting·Listed Jul 2024
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
for Alzheimer's Disease
Drug: KarXT
Sites in Fullerton, Irvine +24 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 60 - 85
Code: NCT06976203·Phase 3·Recruiting·Listed May 2025
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for Urothelial Cancer
Sites in Fullerton, Palo Alto +31 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07106762·Phase 2, Phase 3·Recruiting·Listed Aug 2025
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for Advanced Solid Tumor
Sites in Fullerton, Newport Beach +22 more locations
Sponsor: Synthekine
Sex: All·Age: 18+
Code: NCT05098132·Phase 1, Phase 2·Recruiting·Listed Oct 2021
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
for Secondary Progressive Multiple Sclerosis (SPMS)
Drug: Remibrutinib
Sites in Fullerton, West Hollywood +33 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 65
Code: NCT07225504·Phase 3·Recruiting·Listed Nov 2025
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for Small Cell Lung Cancer
Sites in Fullerton, Los Angeles +28 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06203210·Phase 3·Recruiting·Listed Jan 2024
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for Metastatic Non-small Cell Lung Cancer
Sites in Fullerton, Newport Beach +35 more locations
Sponsor: NovoCure GmbH
Sex: All·Age: 18+
Code: NCT06216301·Phase 3·Recruiting·Listed Jan 2024
Top Research Study Locations in Fullerton
Researchers run research studies in Fullerton, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Medical Foundation | Carcinoma, Non-Small-Cell Lung, Esophageal Squamous Cell Carcinoma, Advanced Solid Tumor | 30 |
| Providence St. Jude Medical Center | Advanced Breast Cancer, Advanced Ovarian Cancer, Advanced Solid Tumor | 7 |
| Retina Consultants of Orange County | AMD, Diabetic Macular Edema (DME), Geographic Atrophy | 5 |
| Neurology Center of North Orange County | AD, Alzheimer Disease, Cognitive Impairment | 4 |
| Marshall B. Ketchum University | Amblyopia, Dry Eye Disease (DED), Myopia | 3 |
| St. Jude Medical Center | Advanced Non-Small-Cell Lung Cancer, Atrial Fibrillation, Central Line Associated Blood Stream Infections (CLABSI) | 3 |
| Fullerton Neuro and Headache Ctr | Generalized Myasthenia Gravis, Secondary Progressive Multiple Sclerosis (SPMS) | 2 |
| Fullerton Neurology and Headache Center | Alzheimer's Disease, Secondary Progressive Multiple Sclerosis | 2 |
| Providence Saint Jude Medical Center | Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | 2 |
| Providence - St. Jude Medical Center | Hypothyroidism, Non Small Cell Lung Carcinoma | 2 |
| Providence Medical Foundation-Oncology | Breast Neoplasms, Diffuse Large B-Cell Lymphoma | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Adverum | Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | 1 |
| Alliance Surgery Center, Inc | Lumbar Spinal Stenosis | 1 |
| Clinical Research Providence Medical Foundation | Small Cell Lung Cancer | 1 |
| Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| Davita Fullerton Dialysis Center | End Stage Kidney Disease | 1 |
| Investigative | Solid Tumors | 1 |
| Laguna Surgery Center | Lumbar Spinal Stenosis | 1 |
| Local Institution - 0162 | Urothelial Cancer | 1 |
| Local Institution - 0504 | Non-Small Cell Lung Cancer | 1 |
| National Institute of Clinical Research, Inc. | End Stage Kidney Disease | 1 |
| Pa0019 119 | Axial Spondyloarthritis, Psoriatic Arthritis | 1 |
| Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center | Anaplastic Lymphoma Kinase (ALK) Positive, Non-small Cell Lung Cancer (NSCLC) | 1 |
| Providence Medical Foundation - Fullerton | Colorectal Cancer | 1 |
Active & Upcoming Studies in Fullerton (2026)
Recruiting trials in Fullerton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (46 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) · Phase 3 · Ono Pharmaceutical Co., Ltd.
Eye & vision (8 active studies)
- Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration · Phase 2 · Adverum Biotechnologies, Inc.
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
Neurology & pain (5 active studies)
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis · Phase 3 · Zenas BioPharma (USA), LLC
Cardiovascular (2 active studies)
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure · Phase 3 · AstraZeneca
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Diabetes & metabolic (1 active study)
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight · Phase 3 · Novo Nordisk A/S
Common conditions studied in Fullerton
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Advanced Solid Tumor (3 active studies)
- Breast Neoplasms (3 active studies)
- Esophageal Squamous Cell Carcinoma (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Amblyopia (2 active studies)
Leading research sponsors in Fullerton
- Merck Sharp & Dohme LLC
- Janssen Research & Development, LLC
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Fullerton?
There are approximately 90 recruiting clinical trials in Fullerton, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fullerton pay participants?
Most recruiting trials in Fullerton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fullerton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fullerton?
The most common conditions under active study in Fullerton include Carcinoma, Non-Small-Cell Lung (4), Advanced Solid Tumor (3), Breast Neoplasms (3), Esophageal Squamous Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fullerton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fullerton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fullerton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fullerton?
Recruiting research sites in Fullerton include Providence Medical Foundation, Providence St. Jude Medical Center, Retina Consultants of Orange County, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fullerton right now?
The largest active categories in Fullerton are Cancer & tumors (46), Eye & vision (8), Neurology & pain (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in California
Los Angeles, CA(1,993)San Francisco, CA(1,337)San Diego, CA(760)Palo Alto, CA(654)Sacramento, CA(583)Duarte, CA(546)La Jolla, CA(542)Orange, CA(517)Stanford, CA(424)Irvine, CA(388)Long Beach, CA(210)Walnut Creek, CA(186)Newport Beach, CA(183)Santa Monica, CA(178)Oakland, CA(171)Beverly Hills, CA(166)Torrance, CA(165)Loma Linda, CA(161)Anaheim, CA(124)Fresno, CA(104)Pasadena, CA(104)Santa Rosa, CA(104)Glendale, CA(98)Redwood City, CA(97)Fountain Valley, CA(94)Riverside, CA(91)Lancaster, CA(89)Los Alamitos, CA(85)Fremont, CA(82)Huntington Beach, CA(77)San Jose, CA(75)Santa Barbara, CA(73)Roseville, CA(71)Vallejo, CA(65)Modesto, CA(64)Bakersfield, CA(61)Northridge, CA(60)Thousand Oaks, CA(60)Chula Vista, CA(57)Upland, CA(57)Berkeley, CA(56)Burbank, CA(54)Santa Clara, CA(49)Stockton, CA(49)Oceanside, CA(48)Pomona, CA(48)Santa Ana, CA(47)Garden Grove, CA(45)Bellflower, CA(44)San Leandro, CA(43)Santa Maria, CA(43)Downey, CA(42)Tarzana, CA(42)Oxnard, CA(41)San Luis Obispo, CA(41)Davis, CA(40)San Rafael, CA(40)Arroyo Grande, CA(37)Dublin, CA(37)La Mesa, CA(37)